You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / TTK HEALTHCARE

TTK HEALTHCARE
Intrinsic Value | Fundamental Analysis

Returns | 1W : -3.3% , 1M : 6.2%,1Y : 44.9%
BOM : 507747     NSE : TTKHLTCARE    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 18,2021
Price(EOD): Rs. 622.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 878.29 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
TTK HEALTHCARE -3.3% 6.2% 44.9%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -2.7% 36.8%
DR REDDYS LABORATORIES -3.2% 0.9% 32.7%
DIVIS LABORATORIES -4.4% 3.7% 87%
CIPLA -1.6% 3.9% 48.5%
BIOCON -3.1% 4.1% 0.7%
AUROBINDO PHARMA -4.2% -7.2% 22%
LUPIN -3% -4% 25.2%
TORRENT PHARMACEUTICALS -2.7% 6.3% 16%


FUNDAMENTAL ANALYSIS OF TTK HEALTHCARE

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than TTK HEALTHCARE Premium


VALUATION OF TTK HEALTHCARE

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
71.43
P/E Calculated based on EPS of 8.72
[ Mar2020 - Standalone Results ]

3.6
P/B Calculated based on Book Value of 173.09
[ Mar2020 - Standalone Results ]

1.51
P/S Calculated based on Revenues of 583.575 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than TTK HEALTHCARE Premium


FAIR VALUE OF TTK HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
86%
0%
9%

SHARE PRICE MOMENTUM OF TTK HEALTHCARE

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.12
0.12
0.21
0.15
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
1.16%
24.58%
32.4%
34.59%
32.79%
440.2%
1393.52%
2346.1%
QtrlyTrend
8
Latest Qtr: Mar2021

TTK HEALTHCARE related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is TTKHLTCARE good for long term investment?

As on 18-Jun-2021, the Fundamentals of TTKHLTCARE are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of TTK HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TTKHLTCARE UnderValued or OverValued?

As on 18-Jun-2021, TTKHLTCARE is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of TTKHLTCARE ?

As on 18-Jun-2021, the Intrinsic Value of TTKHLTCARE is Rs. 571.16 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 334.18
Fair Value [Median EV / Sales Model] : Rs. 621.21
Fair Value [Median Price / Sales Model] : Rs. 571.16
Median Fair Value of TTKHLTCARE : Rs. 571.16

Is TTKHLTCARE trading at a Premium or Discount?

As on 18-Jun-2021, TTKHLTCARE is trading at a Premium of 9% based on the Median Intrinsic Value!

Is it right time to buy TTKHLTCARE shares?

As on 18-Jun-2021, TTKHLTCARE is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Financial Performance of Industry Peers of TTKHLTCARE?

Check out Annual Financials of Industry Peers
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with TTKHLTCARE?

Compare Analytics
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
TTK HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z